中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Retrospective Natural History Study of Retinitis Pigmentosa

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态主动,不招募
赞助商
SparingVision

关键词

抽象

This is natural history study of rods and cones degenerations in patients with Retinitis Pigmentosa (RP) caused by pathogenic mutations in RHO, PDE6A or PDE6B gene mutations.

描述

This is a retrospective, longitudinal, observational case history study to determine the natural history of rods and cones degeneration in patients diagnosed with RP caused by pathogenic mutations in genes with selective expression in rods: rhodopsin (RHO), phosphodiesterase 6A (PDE6A) or phosphodiesterase 6B (PDE6B).

113 participants will be enrolled in this study at the single center: CHNO-CIC Quinze-Vingt Paris in France.

日期

最后验证: 06/30/2019
首次提交: 06/03/2019
提交的预估入学人数: 06/03/2019
首次发布: 06/04/2019
上次提交的更新: 07/09/2019
最近更新发布: 07/10/2019
实际学习开始日期: 09/30/2018
预计主要完成日期: 07/30/2019
预计完成日期: 08/30/2019

状况或疾病

Retinitis Pigmentosa (RP)

-

资格标准

有资格学习的性别All
取样方式Non-Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- Patients with RP caused by pathogenic mutations in RHO, PDE6A or PDE6B genes.

Exclusion Criteria:

- Patients with a pathogenic mutation in any other gene known to be involved in RP.

- Patients with any ocular disorder other than RP, likely to impact the retinal function.

结果

主要结果指标

1. Visual acuity [2 years]

Progression of disease over time as measured by best corrected visual acuity (BCVA) (ETDRS, Snellen) and refraction

2. Visual field [2 years]

Progression of disease over time as measured by visual fields (kinetic and static)

3. Spectral Domain Optical Coherence tomography (SD-OCT) [2 years]

Progression of disease over time as measured by SD-OCT (EZ length, ELM length, ONL thickness, macular volume).

4. Fundus Autofluorescence (FAF) [2 years]

Progression of disease as measured by FAF (Hyperautofluorescent ring)

次要成果指标

1. Patients characteristics [2 years]

Age, gender, medical and surgical history, family history and concomitant treatments

2. Clinical diagnosis [baseline (At diagnosis)]

Age and description at onset, clinical signs, relevant treatments and an ophthalmological anamnesis

3. Genetic diagnosis [baseline (At diagnosis)]

Mutated gene, identified pathogenic mutation

4. Electroretinogram (ERG) [baseline (At diagnosis)]

Photopic and scotopic full field

5. Color vision [2 years]

15 Hue Desaturated Lanthony

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge